Page last updated: 2024-11-05

tranexamic acid and Prostatic Neoplasms

tranexamic acid has been researched along with Prostatic Neoplasms in 5 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
"Prostate cancer and benign prostatic hyperplasia have an increased incidence with aging."2.58Systematic review and meta-analyses of tranexamic acid use for bleeding reduction in prostate surgery. ( Cavalheiro, BT; de Oliveira Filho, GR; Longo, MA, 2018)
"Tranexamic acid is a safe drug to treat hyperfibrinolysis during prostate resection."2.49[Current strategies to minimize of blood loss during radical prostatectomy]. ( Hachenberg, T; Strang, CM, 2013)
"Fibrinogen level was normalized within two days (2."1.43Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report. ( Cvetković, Z; Kulić, A; Libek, V, 2016)
"To determine whether radiation combined with Trans-4-AminoMethyl Cyclohexane carboxylic Acid (AMCA, or tranexamic acid, Cyklokapron) results in a better tumor response than radiation alone."1.32Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA. ( Gebbink, MF; Kal, HB; Struikmans, H; Voest, EE, 2004)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kulić, A1
Cvetković, Z1
Libek, V1
Longo, MA1
Cavalheiro, BT1
de Oliveira Filho, GR1
Strang, CM1
Hachenberg, T1
Kal, HB1
Struikmans, H1
Gebbink, MF1
Voest, EE1
Hodson, A1
Hunt, BJ1

Reviews

2 reviews available for tranexamic acid and Prostatic Neoplasms

ArticleYear
Systematic review and meta-analyses of tranexamic acid use for bleeding reduction in prostate surgery.
    Journal of clinical anesthesia, 2018, Volume: 48

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Humans; Incidence; Male; Prostatec

2018
[Current strategies to minimize of blood loss during radical prostatectomy].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2013, Volume: 48, Issue:7-8

    Topics: Adult; Aged; Anesthesia, Epidural; Antifibrinolytic Agents; Blood Loss, Surgical; Fibrinolysis; Flui

2013

Other Studies

3 other studies available for tranexamic acid and Prostatic Neoplasms

ArticleYear
Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report.
    Vojnosanitetski pregled, 2016, Volume: 73, Issue:9

    Topics: Adenocarcinoma; Antifibrinolytic Agents; Biomarkers; Blood Coagulation Disorders; Blood Coagulation

2016
Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2004, Volume: 180, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Antifibrinolytic Agents; Cell Line, Tumor; Chemotherapy, Adjuvant;

2004
A bleeding tongue - acute presentation of fibrinolysis.
    International journal of laboratory hematology, 2007, Volume: 29, Issue:5

    Topics: Adenocarcinoma; Aged; Antifibrinolytic Agents; Fibrinolysis; Hemorrhage; Humans; Male; Prostatic Neo

2007